Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019)
Clinical trial NCT01006616 · TERMINATED
Trial details
- NCT number
- NCT01006616
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-03-01
- Enrollment
- 616
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.